+Áñ°Üã±â
°«ÇÇÇøô ¾Û   ¼º°æ°øºÎ±³Àç  ¾î¸°ÀÌ ¹Ì´Ï¼­Àç  »õ½ÅÀÚ¼±¹°  ¼º°æÁÖ¼®  °ñ¶ó´ã±âLIST  ³ó¾îÃ̱³È¸ÀåÅÍ

  • Ȩ
  •  
  •  
  •  
  •  
 
¼º°æ¿¬±¸

¼º°æ±âȹ

»¡°£Ã¥ THE RED BOOK   ¿ì¸®´Â Áúº´ÀÇ °íÅë ¼Ó¿¡ »ì ÀÌÀ¯°¡ ¾ø´Ù
¼Òµæ°øÁ¦µµ¼­Á¤°¡Á¦ 
       
ÆÛ°¡±â
  
ÀúÀÚ : ´ë¸¯ ±è  |  ÃâÆÇ»ç : µµ¼­ÃâÆÇ ±Û»ù
¹ßÇàÀÏ : 2024-04-23  |  (142*208)mm 156p  |  978-89-91358-68-3
  • ÆǸŰ¡ : 10,000¿ø ¡æ 9,000¿ø (10.0%, 1,000¿ø¡é)
  • Àû¸³±Ý : 500¿ø (5.0%)
  • ¹è¼Ûºñ : 2,300¿ø (12,000¿ø ÀÌ»ó ÁÖ¹®½Ã ¹«·á¹è¼Û)
  • ¿ÀÀü 9½Ã ±îÁö °áÁ¦ÇÏ¸é ¿À´Ã Ãâ°í µË´Ï´Ù. 
    °«ÇÇÇÃ Ãâ°í
¹«ÀÌÀÚ Ä«µå¼³¸í
ÁÖ¹®¼ö·®  
±Ç  
 
³»ºÎÀ̹ÌÁöÀÔ´Ï´Ù. Å©°Ô º¸½Ã·Á¸é ¾Æ·¡ ±×¸²À» Ŭ¸¯Çϼ¼¿ä. ['¾ÕÇ¥Áö' Æ÷ÇÔ ÃÑ 29 ÆäÀÌÁö]
¸ðµÎ°¡ ÇÑ ¹øÀº ²À Àоî¾ß Çϴ å

¸ÅÀÏ ¹èºÎ¸£°Ô Àß ¸Ô°í Àß »ç´Â ¿ì¸®
±×·¯³ª ¾ÆÇ À̵éÀº ´Ã¾î¸¸ °£´Ù!
¿ì¸®´Â ¿Ö ¾ÆÇñî? ¹«¾ùÀÌ ¹®Á¦Àϱî? ¹«¾ùÀ» ¸Ô¾î¾ß ÇÒ±î?
Áúº´ÀÇ ¿øÀÎÀ» ¾Ë°í ÇØ°áÃ¥À» ã¾Æ°£´Ù!

¼ö ¸¹Àº Ä¡·á ¹°ÁúÀ» °³¹ßÇÑ Darrick Kim ¾àÇйڻ簡 ÀüÇÏ´Â ¸ðµÎ°¡ °Ç°­ÇÏ°Ô »ì ¼ö ÀÖ´Â ¹æ¹ý! ´©±¸º¸´Ù ½±°í ¸íÄèÇÏ°Ô Á¦½ÃÇÑ´Ù.

¸öÀÌ ºÒÆíÇØ º´¿øÀ» °¡°í, Áø´ÜÀ» ¹Þ°í ¾àÀ» ¸Ô¾îµµ ÀϽÃÀûÀÎ Áõ»ó ¿ÏÈ­¿¡ ±×Ä¡°í Áúº´Àº ³´Áö ¾Ê´Â´Ù. ÀÌ·± Áúº´µéÀÇ ¿øÀÎÀº ¹«¾ùÀϱî? ¾î¶»°Ô ÇØ¾ß ÀÌ·± Áúº´¿¡¼­ ÇعæµÇ¾î °Ç°­ÇÑ ¸öÀ¸·Î ÇູÇÏ°Ô »ì ¼ö ÀÖÀ»±î?
ºñ°¨¿°¼º ¸¸¼ºÁúȯÀÇ ¿øÀÎÀ» ¹àÈ÷°í ÀÏ»ó »ýÈ°¿¡¼­ÀÇ ÀÛÀº ³ë·ÂÀ¸·Î °Ç°­À» Áöų ¼ö ÀÖ´Â ¹æ¹ýÀ» ³ª´«´Ù.

¿À·¡ »ç´Â °Íº¸´Ù ¾î¶»°Ô »ç´ÂÁö°¡ ´õ Áß¿äÇÏ´Ù. °Ç°­ÇÑ »î¿¡¼­ ÁøÁ¤ÇÑ »îÀÇ °¡Ä¡¸¦ ½ÇÇöÇÒ ¼ö Àֱ⠶§¹®ÀÌ´Ù. ¿ì¸®´Â Áúº´ÀÇ °íÅë ¼Ó¿¡ »ì ÀÌÀ¯°¡ ¾ø´Ù.
ÀúÀÚ¼Ò°³ 8
̵̧ȍ 10
¼­¹® 13

¿°ÁõÀ̶õ? 20
À¯»ê±Õ°ú ºÎÆÐ±Õ 22
À¯»ê±ÕÀÇ ¿ªÇÒ°ú ¿ÀÇØ 24
±èÄ¡°¡ ¿Ö ¸ö¿¡ ÁÁÀ»±î¿ä? 26
ºÎÆбÕÀ̶õ? 29
¸ö ¾È ºÎÆбÕÀÌ ¸¸µé¾î ³»´Â µ¶¼Ò 31
°£ÀÇ ÀÛ¿ë 33
»ç¶÷ÀÇ ¸öÀº ¸¹Àº ºÎÇ°À¸·Î ¸¸µé¾îÁ® ÀÖ´Ù 34
´ÙÀ̾îÆ®¿Í ¿ä¿ä Çö»óÀÇ °ü°è, ´ÙÀ̾îÆ®¿¡ ½ÇÆÐÇÏ´Â ÀÌÀ¯ 38
º¹½ÀÇϱâ 41
°í¹ÎÇغ¸±â : ¹«¾ùÀÌ Áúº´ÀÇ ¿øÀÎÀΰ¡? 43
¿°Áõ Áúȯ°ú È­ÇÐ ¹æºÎÁ¦ÀÇ ¿¬°ü¼º 48
È­ÇÐ ¹æºÎÁ¦°¡ µé¾îÀÖ´Â ¹Ð°¡·ç°¡ ¾ó¸¶³ª ³ª»Ü±î? 50
Áúº´ÀÇ ¿øÀÎÀº? 56
¿µ¾ç½ÇÁ¶¿Í Áúº´ÀÇ °ü°è 57
°Ç°­ÇÑ ¸öÀ» À¯ÁöÇÏ´Â ¹æ¹ý 62
¾ßä ½º¹«µð ¸¸µå´Â ¹æ¹ý 64
ºñŸ¹ÎB±º°ú ¹Ì³×¶ö 68
À½½Ä ¼ÓÀÇ ¹«±âÁú 72
¸öÀ» ¿òÁ÷ÀÌ´Â ÈûÀÇ ¿øõ ½ÅÁø´ë»ç ÇØ´ç°úÁ¤°ú À¯±â¹°ÀÇ ´ë»ç ȸ·Î 75
Á¾ÇÕÀûÀÎ °á·Ð 80
Áúº´ÀÌ À¯ÀüµÇ´Â ÀÌÀ¯, ¿Ö °Ç°­Àº ´ë¹°¸²µÇ´Â °É±î? 84
À¯ÀüÀÚ¿Í ¼¼Æ÷ ½ÅÈ£Àü´Þ 89
¿°Áõ ÀÎÀÚµé 94
¿µ¾ç½ÇÁ¶ ȯÀÚ¿Í ¾Ï 98
Àå ³» ±ÕÀÌ ¿ì¸®ÀÇ »ý°¢°ú ÇൿÀ» Á¶ÀýÇÑ´Ù 100
ADHD ¿Í Autism(ÀÚÆóÁõ) 103
ºñŸ¹ÎC¸¦ ¸¹ÀÌ ¸Ô¾î¾ß ÇÏ´Â ÀÌÀ¯ 107
°Ç°­À» À§ÇØ ÁÖÀÇÇÒ °Í°ú ¸ÔÁö ¸»¾Æ¾ß ÇÏ´Â °Íµé 115
ÃÑ °á·Ð 150
Àå ³» ¹ÚÅ׸®¾Æ Á¾·ùµé ¸î °¡Áö ¿¹ 154
Àå ³» À¯»ê±Õ Á¾·ùµé ¸î °¡Áö ¿¹ 155
´ë¸¯ ±è
(Darrick Kim)
¾à·Â
-UC Irvine ÇкΠ¹× ´ëÇпø Á¹¾÷ (PhD, Organic Chemistry)
-UC Irvine, School of Medicine, Department of Neuropathology, Research Associate
-Purdue University, College of Pharmacy (¾à´ë) Postdoctoral Stint (Drug Discovery
against Solid Tumor Using Natural Products)
-Àϸ®³ëÀÌ ÁÖ¸³´ë ¾à´ë ±³¼ö ¿ªÀÓ (University of Illinois at Chicago, College of
Pharmacy, Department of Medicinal Chemistry and Pharmacognosy, Program for
Collaborative Research in Pharmaceutical Science (PCRPS) and Functional Foods for Health)
-International University of the Health and Sciences, School of Medicine
-¼¼°è ÃÖÃÊ·Î ¾àÃʼººÐ¿¡¼­ ¾ËÃ÷ÇÏÀÌ¸Ó ¿¹¹æ Ä¡·áÁ¦ °³¹ß ¹æ¹ý ÇÐ°è º¸°í
-¾ËÃ÷ÇÏÀÌ¸Ó Ä¡¸Å ¿¹¹æ Ä¡·áÁ¦ ¹°Áú ¹× Á¦Á¶°øÁ¤¿¡ °üÇÑ ¹Ì±¹ ƯÇã ȹµæ ¹× Ãâ¿ø (11 °Ç)
-³ì³»Àå ¿¹¹æ ¹× Ȳ¹Ýº¯¼º Ä¡·á ¼ººÐ ƯÇã ȹµæ
-Ç×¾ÏÁ¦ ¹× ¿¬±¸¿¡ °üÇÑ Æ¯Çã ȹµæ (13 °Ç)
-¼ºº´ ¿¹¹æ Ä¡·áÁ¦ °³¹ß ƯÇã ȹµæ
-±¹Á¦ ÇмúÁö¿¡ 40 ¿©Æí ¿¬±¸³í¹® ¹ßÇ¥
-Åõ¸Ó¸¯ (°­È²)¿¡¼­ ³ú½Å°æ ¼¼Æ÷ È°¼º ¹× ¾ËÃ÷ÇÏÀÌ¸Ó Ä¡·á ¹°Áú Calebin-A ¸¦ ¼¼°èÃÖÃÊ·Î ¹ß°ß Çа躸°í

ÇöÀç
-Korea Life Source (ÁÖ) Founder/CEO
-Core Life Source, Inc., Founder/CEO
-CurXceL Corp., Founder/CEO
-GLLC (Global Life Laboratory Corp., Co-Founder/Director/Board Member
-Joh-Dar Corp. Co-Founder/Chief Science £¦ Technology Officer

Journal Editorial/Reviewer Positions

-Journal of Natural Products
-Bioorganic and Medicinal Chemistry
-Journal of Organic Chemistry
-Organic Letters
-Journal of Agricultural and Food Chemistry
-Food and Chemical Toxicology
-Combinatorial Chemistry £¦ High Throughput Screening

Major Achievements

-Discovery and development of drug candidates for treatment and prevention of AD
-Discovery and development of Calebin-A
-Discovery and development of drug candidates for treatment against solid tumors
-Discovery and development of drug candidates for treatment against melanoma
-Discovery and development of drug candidates for treatment against glaucoma and macular degeneration
-Discovery and development of drug candidates and formulation for treatment against chronic inflammatory diseases
-Discovery and development of methods to treat chronic inflammatory diseases
-Development of Optimum Health Program (OHP) programs to treat non- communicable inflammatory diseases
½Ã¸®Áî ¼Ò°³ | ¼¼Æ® | ¼¼Æ®³¹±Ç±¸¼º
¼¼Æ® »óÇ°ÀÌ ¾ø½À´Ï´Ù.
ÆòÁ¡
À̸§
°ø°¨
ÀÛ¼ºÀÏ
´äº¯À¯¹«
¹®ÀÇ Á¦¸ñ
À̸§
ÀÛ¼ºÀÏ

µµ¼­¸í»¡°£Ã¥ THE RED BOOK
ÀúÀڴ븯 ±è
ÃâÆǻ絵¼­ÃâÆÇ ±Û»ù
Å©±â(142*208)mm
Âʼö156
Á¦Ç°±¸¼º»óÇ°¼³¸í ÂüÁ¶
¹ßÇàÀÏ2024-04-23
¸ñÂ÷ ¶Ç´Â Ã¥¼Ò°³»óÇ°¼³¸í ÂüÁ¶
¹è¼Û¹æ¹ý Åùè
¹è¼Û¿¹»ó±â°£ [ ÁÖ¹® ] ÈÄ [1~2ÀÏ À̳»] [ ÇÑÁøÅùè ](À¸)·Î Ãâ°í ¿¹Á¤ÀÔ´Ï´Ù. (Åä/ÀÏ/°øÈÞÀÏ Á¦¿Ü)
¼ÒºñÀÚ º¯½É(±¸¸ÅÂø¿À)¿¡ ÀÇÇÑ ¹ÝÇ°ºñ¿ë Æíµµ 2,500¿ø (ÃÖÃÊ ¹è¼Ûºñ ¹«·áÀÎ °æ¿ì 4,800¿ø)
û¾àöȸ°¡ ºÒ°¡´ÉÇÑ °æ¿ì »óÇ° ¼ö·ÉÀϷκÎÅÍ 7ÀÏÀÌ Áö³­ °æ¿ì ¹× ÀüÀÚ»ó°Å·¡µî¿¡¼­ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·ü µî¿¡ ÀÇÇÑ Ã»¾àöȸ Á¦ÇÑ »çÀ¯¿¡ ÇØ´çÇÏ´Â °æ¿ì û¾àöȸ°¡ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.
±³È¯ ¹ÝÇ° º¸Áõ Á¶°Ç ¹× Ç°Áúº¸Áõ±âÁØ ¼ÒºñÀÚºÐÀïÇØ°á±âÁØ ¹× °ü°è¹ý·É¿¡ µû¸¨´Ï´Ù.
ÁÖ¹®Ãë¼Ò ¹× ´ë±Ý ȯºÒ ¹æ¹ý ¸¶ÀÌÆäÀÌÁö 1:1¹®ÀǸ¦ ÅëÇØ ½ÅûÇÒ ¼ö ÀÖÀ¸¸ç, ÆǸÅÀÚ´Â ÀüÀÚ»ó°Å·¡µî¿¡¼­ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¹Ù¿¡ µû¸¥ Áö¿¬ÀÌÀÚ Áö±ÞÀÇ Ã¥ÀÓÀÌ ÀÖ½À´Ï´Ù.
A/S °ü·Ã ÀüÈ­¹øÈ£ 1522-0091
°Å·¡¿¡ °üÇÑ ÀÌ¿ë¾à°ü È®ÀÎ ¹æ¹ý ´ç»ç ȨÆäÀÌÁö ÇÏ´ÜÀÇ ÀÌ¿ë¾à°ü ¸µÅ©¸¦ ÅëÇØ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.
 ÀúÀÚ(´ë¸¯ ±è) ½Å°£ ¸ÞÀϸµ   ÃâÆÇ»ç(µµ¼­ÃâÆÇ ±Û»ù) ½Å°£ ¸ÞÀϸµ  
¹è¼ÛÁ¤º¸

1. º» »óÇ°Àº [ ÁÖ¹® ] ÈÄ [1~2ÀÏ À̳»] [ ÇÑÁøÅùè ](À¸)·Î Ãâ°í ¿¹Á¤ÀÔ´Ï´Ù. (Åä/ÀÏ/°øÈÞÀÏ Á¦¿Ü)
2. ¹è¼Ûºñ : 2,300¿ø (12,000¿ø ÀÌ»ó ÁÖ¹®½Ã ¹«·á¹è¼Û)

¹ÝÇ°±³È¯Á¤º¸ ¹× ÀýÂ÷

1. »óÇ° ÇÏÀÚ°¡ ¾Æ´Ñ ¼ÒºñÀÚÀÇ ´Ü¼øº¯½É ¶Ç´Â ±¸¸ÅÂø¿À¿¡ µû¸¥ ±³È¯/¹ÝÇ°Àº »óÇ° ¼ö·ÉÀϷκÎÅÍ 7ÀÏ À̳»¿¡ ½Åû °¡´ÉÇϸç,
»óÇ° ȸ¼ö ¹× ¹è¼Û¿¡ ÇÊ¿äÇÑ ºñ¿ë ¿Õº¹¹è¼Ûºñ [ 4,800 ]¿øÀº °í°´²²¼­ ºÎ´ãÇÏ¼Å¾ß ÇÕ´Ï´Ù.

2. °«ÇÇÇøô °í°´¼¾ÅÍ¿¡ ¹ÝÇ° ½ÅûÀ» ÇϽŠÈÄ ¾È³»¿¡ µû¶ó ¹è¼ÛµÈ Åùè»ç¸¦ ÅëÇØ ¹ÝÇ°ÇÏ½Ã¸é µË´Ï´Ù.
ºü¸¥ 󸮸¦ À§ÇØ ÁÖ¹®ÀÚ¸í, ¿¬¶ôó, ¹ÝÇ°/±³È¯ »çÀ¯¸¦ ¸Þ¸ðÇÏ½Ã¾î ¹Ú½º ¾È¿¡ µ¿ºÀÇØÁÖ¼¼¿ä.

3. »óÇ°ÀÇ ±³È¯/¹ÝÇ°/º¸Áõ Á¶°Ç ¹× Ç°Áú º¸Áõ ±âÁØ
   »óÇ°¿¡ ÇÏÀÚ°¡ Àְųª ³»¿ëÀÌ Ç¥½ÃÁ¤º¸¿Í »óÀÌÇÒ °æ¿ì¿¡´Â ¹®Á¦Á¡ ¹ß°ß ÈÄ 30ÀÏ(´Ü, ¼ö·ÉÀϷκÎÅÍ 3°³¿ù) À̳»¿¡ ¹«»óÀ¸·Î ±³È¯Çص帳´Ï´Ù.

4. »óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ¹ÝÇ°, ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº ¼ÒºñÀÚºÐÀïÇØ°á±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ µû¶ó ¹ÞÀ¸½Ç ¼ö ÀÖ½À´Ï´Ù.

5. ´ë±Ý ȯºÒ ¹× ȯºÒ Áö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÕ´Ï´Ù.

¹ÝÇ°±³È¯ ºÒ°¡ ¾È³»

1. ¹ÝÇ°¿äû ±â°£ÀÌ Áö³µÀ» °æ¿ì
2. ¼ÒºñÀÚ¿¡°Ô Ã¥ÀÓÀÌ ÀÖ´Â »çÀ¯·Î »óÇ°ÀÌ ÈÑ¼ÕµÈ °æ¿ì.
3. ¼ÒºñÀÚÀÇ »ç¿ë ¶Ç´Â ÀϺΠ¼Òºñ·Î »óÇ°ÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
4. ½Ã°£ÀÌ Áö³ª ´Ù½Ã ÆǸÅÇϱ⠰ï¶õÇÒ Á¤µµ·Î »óÇ°ÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
5. ºñ´Ò µîÀ¸·Î Æ÷ÀåµÇ¾î ÀÖ´Â »óÇ°ÀÇ Æ÷ÀåÀ̳ª ºÀÀÎ ¶óº§ÀÌ ÈѼյÆÀ» °æ¿ì
6. º¹Á¦°¡ °¡´ÉÇÑ »óÇ°ÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì(À½¹Ý, DVD, ¼ÒÇÁÆ®¿þ¾î µî)
7. ÀÎ¼â ¹× °í°´ ¿äû¿¡ ÀÇÇÑ ÁÖ¹®Á¦ÀÛ »óÇ°ÀÏ °æ¿ì
8. ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ ÀÇÇÑ ¹ÝÇ°±ÔÁ¤ÀÌ ÆǸÅÀÚ°¡ ÁöÁ¤ÇÑ ¹ÝÇ°Á¶°Çº¸´Ù ¿ì¼±ÇÕ´Ï´Ù.
»óÇ°º° ±³È¯/¹ÝÇ°ºÒ°¡ »çÇ×
ÀÇ·ù/ÀâÈ­ ¡¤ »óÇ° »óÅ°¡ ¿ÂÀüÄ¡ ¸øÇÑ °æ¿ì¡¤¼¼Å¹À» Ç߰ųª ¼ö¼±ÇßÀ» °æ¿ì
¼ÒÇÁÆ®¿þ¾î ¡¤ CD, DVD, VCD, VIDEO Tape µî ¹Ú½º Æ÷ÀåÀ» Á¦°ÅÇ߰ųª ¹ÙÄڵ尡 ¼Õ»óµÈ °æ¿ì
¡¤ ÀåÂø ¶Ç´Â ¿î¿µÃ¼Á¦ µîÀ» ¼³Ä¡ÇßÀ» °æ¿ì
½ºÆ÷Ã÷ ¡¤ »ç¿ë ÈçÀûÀÌ ÀÖ´Â °æ¿ì
°¡±¸/ÀÎÅ׸®¾î ¡¤ ÁÖ¹® Á¦ÀÛÀÇ °æ¿ì ½ÇÃø ÈÄ Á¦ÀÛ ÁßÀÏ °æ¿ì
½ÄÇ° ¡¤ ¹ß¼Û°ú µ¿½Ã¿¡ »óÇ°ÀÇ ÈѼÕÀÌ ÁøÇàµÇ´Â °æ¿ì
¾Ç±â/À½Ç⿵»ó±â±â ¡¤ »ç¿ë ÈçÀûÀ̳ª ¼³Ä¡¸¦ ÇÑ °æ¿ì
¡¤ ºÎÇ°ÀÌ ¸Á½ÇµÇ¾ú°Å³ª ÀÓÀÇ·Î Å»Âø½ÃÄ×À» °æ¿ì